−£34.58m
vs Dec 2024Active10908112Private limited companyAbingdon
AVAXMED LIMITED
Significant control: Anthony Taylor Rowlands (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Avaxmed Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Avaxmed Limited sell?
Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AVAXMED LIMITED is an active private limited company (company number 10908112) incorporated on 9 August 2017, registered in Abingdon. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest full accounts cover the period ending 31 December 2025, showing net assets of −£34.58m and cash of £301k, with 0 employees on average. Turnover was £364k and profit for the year −£5.86m. Net assets fell 20% on the prior period (−£28.72m).
Peer position · net assets
By net assets it sits in the bottom quarter of 124 comparable companies in Oxford (median £954, upper quartile £58k).
02
Ownership and control
- Mr Anthony Taylor Rowlands
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 9 August 20179 yrs ago
- Next accounts due
- 30 September 2027in 338 days
- Confirmation statement due
- 23 August 2027in 300 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£301k
−22%vs Dec 2024£364k
−60%vs Dec 20240
vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£34.58m | £301k | — | — | £364k | −£5.86m | 0 |
| 31 December 2024 | −£28.72m | £388k | — | — | £917k | −£4.91m | 0 |
| 1 January 2024 | — | — | — | — | — | — | — |
Net margin-1609.8%Profit for the year ÷ turnover
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-34,579,281 at 31 December 2025
- Cash at bank of £50,000 or moreCash £301,134
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 9 August 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 338 days
- Confirmation statement duein 300 days
- Accounts period endNet liabilities £34.58m · full accounts
- Accounts period endNet liabilities £28.72m · full accounts
- Accounts period end
- Incorporated
08
Similar companies in Oxford
- OPSYDIA LIMITEDOxford · inc. Jul 2017
- THE FARADAY INSTITUTIONDidcot · inc. Sept 2017
- PIEZOPLASMA LTDOxford · inc. Oct 2017
- PRISM SCIENTIFIC LIMITEDWantage · inc. Oct 2017
- PHYNOVA INNOVATION LIMITEDBanbury · inc. Nov 2017
- INSIGHT MW LIMITEDWitney · inc. Apr 2017
All companies incorporated on 9 August 2017 · in Aug 2017.
09
Reminders for AVAXMED LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.